ライフサイエンスコーパス: go forward

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 refine current systems in obligate parasites go forward.

2 ariables does not permit Bell-type proofs to go forward.

3 d by GWAS should be priorities for the field going forward.

4 ention with respect to the potential impacts going forward.

5 tiology, mechanism and preventive treatments going forward.

6 asures are preferred to reduce heterogeneity going forward.

7 ards further population mortality reductions going forward.

8 nt numbers and reassess abatement approaches going forward.

9 f the important challenges and opportunities going forward.

10 ation will continue to be an important focus going forward.

11 lar mechanistic focus that has great promise going forward.

12 t role for PRO assessment in phase II trials going forward.

13 nd cancer modeling will influence each other going forward.

14 ns and identify challenges for chemogenetics going forward.

15 Going forward, both procedural and pharmacologic interve

16 Going forward, clamping the main renal artery appears un

17 Going forward, co-benefits modeling efforts should be ca

18 Going forward, computational scaffold hopping is thought

19 The go-forward dose is azacitidine 75 mg/m(2) on days 1 thro

20 INTERPRETATION: Going forward, focus should be placed on scenarios that

21 In an on-going forward genetic screen, we identify the Drosophila

22 biotin-streptavidin pair as a benchmark, we go forward in the demonstration of their unique sensitiv

23 Key questions going forward include how and how much new transposition

24 lished by these data, it is inescapable that going forward, investigators will operate under the hypo

25 The most promising strategy going forward is through strong integration of multiple

26 Hence, one of the important challenges going forward is to find ways to pack MOFs efficiently w

27 A challenge going forward is to quantify the contributions of commun

28 Going forward, it is crucial to incorporate HT as a majo

29 Going forward, it will be important to relate the altere

30 hat the most productive avenues for research going forward may be investigations into GAS in its 'nor

31 Going forward, prospective trials should enroll elderly

32 Radiographic progression in the GO-FORWARD study was minimal in all treatment arms, prec

33 In the GO-FORWARD study, changes from baseline to week 24 (cont

34 ho entered early escape), and week 52 in the GO-FORWARD study.

35 toid Arthritis Despite Methotrexate Therapy [GO-FORWARD] study; n =444) were randomly assigned to rec

36 es behind them, trial designs, and means for going forward that may impact favorably on progress.

37 Going forward, the big questions concern the degree to w

38 Going forward, the main challenge will be ensuring that

39 Going forward, the structures will be critically importa

40 Going forward, this work can directly support the develo

41 Going forward, this work now provides a basis for strate

42 ifferences, and how they are being addressed going forward to optimize reporting of CT and MRI findin

43 Going forward, transient LTREs will enhance understandin

44 Going forward, we believe that collaborative efforts sup

45 Going forward, we believe that the use of penumbral imag

46 Going forward, we believe that this model represents a f

47 Going forward, we believe that this unified model can of

48 Going forward, we foresee a paradigm shift from individu

49 Going forward, we offer lessons learned from our collect

50 Going forward, we strive to improve the coverage and con

51 Going forward, well-defined policy direction will be nec

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。